Augmedix, Inc.
Q2 2023 13F Holders
Symbol
AUGX
CUSIP
05105P107
Type
Equity
Class
COM
Num filings
55
Total reported value, excl. options
$135 M
Compare 2023 Q2 to
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q1
2022 Q4
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
Manager
Report Date
Value ($000)
Shares
Option Type